Clinical Trials Browser

Phase 1 × Not yet recruiting × Primary Myelofibrosis × Clear all

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT07527221 2026-04-14

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

Phase 1 Not yet recruiting

40 enrolled

MyeloidOther hematologic neoplasm

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07529951 2026-04-14

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Phase 1 Not yet recruiting

60 enrolled

Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT07379125 2026-01-30

Therapeutic RSK1 Targeting in Myelofibrosis

Phase 1 Not yet recruiting

18 enrolled

Classical hematologyMyeloid

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

Clinical Trials

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Therapeutic RSK1 Targeting in Myelofibrosis